SMaRteN, in partnership with Vitae, is conducting research into the impact of COVID-19 on the working lives of doctoral researchers and research staff. Their aim is to provide insights to enable the sector to better support early career researchers.
The survey will be live for two weeks from Thursday 16th April – Sunday 3rd May. All doctoral students and early career researchers, usually resident in the UK or currently working / studying in the UK are welcome to participate.
You can participate here: www.smarten.org.uk/covid-19-study
Following the closure of the survey, SMaRteN will release anonymised data, enabling researchers and interested stakeholders to engage with analysis. Universities where the sample response size is large enough to ensure anonymity of respondents, may have access to their universities data. Vitae will release a summary of findings, analysed by their team, for university policy makers and funders.
SMaRteN, is the UK Research and Innovation funded student mental health research network www.smarten.org.uk @networkSmarten
Vitae is a non-profit programme supporting the professional and career development of researchers. www.vitae.ac.uk @vitae_news
Government Survey of UK Researchers working under Covid-19
Free Peer Review Workshop for Early Career Researchers










Congratulation on newly published systematic review
Equitable Partnerships in Global Health Research
New Nepal-based paper published last week
Congratulation to HEMS colleagues on their new book!
Book edited by BU academics published
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease